ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO509

A Data-Driven, Evidence-Based, Patient-Centered Optimal Initiation Time for Dialysis Treatment

Session Information

  • Dialysis Vascular Access
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 803 Dialysis: Vascular Access

Author

  • Lee, Eva, The Data and Analytics Innovation Institute, Atlanta, Georgia, United States

Group or Team Name

  • The Kaiser Nephrology Team.
Background

When to start dialysis is an important decision for end-stage CKD care. The difficulty in determining a common gold standard lies partly in the high heterogeneity among patients and available treatment conditions, and in random factors in disease progression / treatment process. This work optimizes pre-dialysis care timing.

Methods

A novel interpretable machine learning model ingests EMR / unstructured data to classify treatment effects and disease prognosis wrt each disease staging and timeline. Our ML model can classify disease-action into the same outcome groups under different conditions/features (hence multiple pathways).

A ML-knowledge treatment timing model is developed to determine an outcome-driven GFR threshold for creating access of various types that maximizes the goodness of patient’s health conditions. Patient preference is incorporated.

Results

11,913 CKD patients with 213,344 GFR s from 2011-2018 were extracted. Among those with initiated dialysis, 67% initiated HD, 32% PD, and 1% CVC. Current 'sub/optimal' initiation shows diverse variance. AI/ML uncovers critical features that affect outcome; and GFR-windows for dialysis initiation and begin dialysis that render good outcome. Table 1 shows 2 interpretable optimal timing and dialysis start time, w.r.t. patient preferences. Only 2-12% of current practice falls within these optimal initiation time. Simulating the 2 policies for 2 years on 1000 patients shows reduction of 16.4%-35% avoidable deaths and 8%-19% increase in utility reward. A new CPG for Phase I implementation was established.

Conclusion

This work has critical health practice implications. We establish the optimal initiative timing model for late-stage CKD management. The novel ML-decision system includes distinct analytic advances as it leverages hidden knowledge within EMR to enable evidence-based patient-centered policy making. The results show that current practice is far from optimal and can be improved considerably. Clinical trial has to be conducted to gauge potential outcome improvemet.

Two optimal timing policies returned from our model (simplified for brevity).
 Policy 1
Policy 1
Policy 2Policy 2
TypeOptimal Initiation time (pre-dialysis care)Begin dialysisOptimal Initiation time (pre-dialysis care)Begin dialysis
HPGFR < 20GFR < 12GFR < 24GRF < 15
PDGFR < 18GFR < 10GFR< 21GFR < 12
SuboptimalWith uremiaGFR < 10
With uremiaGFR < 12
SuboptimalWithout uremiaGFR < 7Without uremiaGFR < 9

Funding

  • Other U.S. Government Support